Kathleen Gondek, PhD, is currently the Global Head of Evidence and Outcomes at Takeda. She is responsible for developing and implementing global outcomes and epidemiology research strategies to establish the value proposition for Takeda products from early development through commercialization. Prior to joining Takeda she was Vice President, US Medical Science Liaisons and Medical Affairs Operations at Bayer HealthCare pharmaceuticals and held a number of positions, of increasing responsibility, within the Health Economics and Outcomes Research (HEOR) function that span a 15-year career with the organization. Kathleen is a coauthor on 45 peer reviewed publications and over 100 presentations and has served on numerous external advisory committees including PCORI’s Rare Disease Advisory Panel. Kathleen holds a Bachelor’s Degree in Pharmacy from the State University of New York at Buffalo and a Ph.D. in Pharmacy Practice and Administrative Science from the University of Maryland at Baltimore. Kathleen was a lecturer at Yale University in the School of Public Health. Kathleen currently serves on the board for the Arts and Business Council of Boston.